A carregar...

Immunotherapy for Prostate Cancer – Recent Developments and Future Challenges

Since the approval of sipuleucel-T for men with metastatic castrate resistant prostate cancer in 2010, great strides in the development of anti-cancer immunotherapies have been made. Current drug development in this area has focused primarily on antigen specific [i.e. cancer vaccines and antibody ba...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schweizer, Michael T., Drake, Charles G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116461/
https://ncbi.nlm.nih.gov/pubmed/24477411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-013-9479-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!